You are on page 1of 11

Selectivity.

Confirmation of identity.
Introduction – selectivity
• Any analytical method must produce analytical signal in response to
the presence of analyte in the sample.
• The signal should be unaffected by other substances in the sample.
• The extent to which this condition is met is termed selectivity.
Introduction – identity confirmation
• When an analytical signal is registered from the sample, it must be
proved that the signal is due to analyte – confirmation of identity.
• Information required for identity confirmation is collected during
validation.

LC-MS is one of the most selective analytical


techniques, which also enables identity confirmation.
Selectivity
• IUPAC definition of selectivity:

The extent to which other substances interfere with the determination


of a substance according to a given procedure.

• Specificity – 100% selectivity.

IUPAC. Compendium of Chemical Terminology, 2nd ed. (1997) Compiled by A. D. McNaught and
A. Wilkinson.
Selectivity terms in validation guidelines
„Selectivity“ „Specificity“
AOAC ICH
EMA NordVal
Eurachem
FDA
IUPAC
Selectivity
• IUPAC definition of selectivity:

The extent to which other substances interfere with the determination


of a substance according to a given procedure.

• Interference …
• substance behaves like analyte.
• interferes with analytical signal (matrix effect).

IUPAC. Compendium of Chemical Terminology, 2nd ed. (1997) Compiled by A. D. McNaught and
A. Wilkinson.
Selectivity in LC-MS
• Selectivity arises from both:
• LC separation process.
• MS detection.
LC selectivity
Peak resolution
4.5

4.0 t RA
tRB  tRA
3.5 Rs 
3.0 t RB 0.85  ( w1 / 2 B  w1 / 2 A )
Detector signal

2.5
tM
2.0
w 1/2(A)
1.5
w 1/2(B)
1.0

0.5 Comp. A Comp. B


0.0
0 2 4 6 8 10 12 14
-0.5
Retention time, min
Required LC selectivity
• Selectivity in terms of peak resolution:
• FDA: RS ≥ 2
• AOAC: RS ≥ 1.5

• Eurachem: demonstrate separation on different column.


• AOAC and ICH: no other compound should be detectable at analyte
retention time when other methods (like IR, NMR and MS) are used.
Why are the requirements so different?
• Pharmaceutical analysis.
• In active pharmaceutical ingredient (API) all synthesis by-products,
degradants and additives may cause side-effects on patients.
• Therefore each component of the sample appears as an analyte and must be
chromatographically separated.
• Pesticide residue analysis in vegetables.
• Vegetable extract is rich in compounds, which may co-elute with analyte.
• Analysis results can still be adequate, if detector is only responsive to analyte
and not matrix components.

You might also like